TabsDetailsBasic DetailsDate: Wednesday, October 31, 2018Type: PublicationMedical Product: fentanyl transdermal systemDescription: Fentanyl transdermal system (FTS) is intended only for patients with prior opioid tolerance. The purpose of this study is to identify the proportion of new FTS users who had evidence of prior opioid tolerance, by dosage strength, in FDA's Sentinel System. Read More Materials: Pharmacoepidemiol Drug Saf. 2018 Oct 31. doi: 10.1002/pds.4677Additional InformationRelated Assessment(s): 2017 ICPE Presentation: Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA's Sentinel SystemCounts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid ToleranceContributorsAuthor(s): Noelle M. Cocoros, Marc R. Larochelle, Jennifer Popovic, Andrew B. Petrone, Cynthia Kornegay, Jing Ju, Judith A. RacoosinCorresponding Author: Noelle M. Cocoros, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA. Email: noelle_cocoros@harvardpilgrim.org
